Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETVACC: PET-CT Evaluation of Vaccine Reactogenicity
NCT04515368Completed
- Sponsor
- Imperial College London
- Start
- Jun 2016
- Primary completion
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Randomised, open-label trial of Hepatitis B vaccine, meningococcal group B vaccine, Fluzone Trivalent and seasonal trivalent influenza vaccine in hepatitis B (HBV), meningococcal disease and influenza (4 arms), sponsored by Imperial College London. Primary endpoints: 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography at 4 hours, 18F-fluorodeoxyglucose or 11C-PBR28 Positron Emission Tomography/Computed Tomography at 1 day and 4 more. Started Jun 2016; status: completed.
02
Drugs
Hepatitis B vaccinemeningococcal group B vaccineFluzone Trivalentseasonal trivalent influenza vaccine
03
Conditions
hepatitis B (HBV)meningococcal diseaseinfluenza
Beyond the preview
Go deeper on NCT04515368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515368.